Amplitude Venture Capital has announced the launch of a CAD $200 million fund to continue its successful investment strategy of building globally competitive Canadian healthcare companies. The Fund is focused on developing platform companies based on outstanding Canadian precision medicine innovation.
The Fund, which Amplitude co-created with cornerstone investor BDC Capital, has closed on more than 50 per cent of its target signalling strong support for Amplitude's investment strategy.
"Canada boasts an innovation-rich healthcare ecosystem that is home to world-leading academic and research centres," said Mr. Madsen. "For too long the capital and expertise necessary to scale potentially game-changing ideas into break-out companies has been largely missing in Canada. Our mission is to unite innovators with acceleration capital and our builder vision to create and scale great companies. This is where Amplitude will focus and thrive."